"Natural Killer T-Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN.
| Descriptor ID |
D055611
|
| MeSH Number(s) |
A11.118.637.555.567.569.290 A15.145.229.637.555.567.569.360 A15.382.490.555.567.569.470
|
| Concept/Terms |
Natural Killer T-Cells- Natural Killer T-Cells
- Killer T-Cell, Natural
- Killer T-Cells, Natural
- Natural Killer T Cells
- T-Cell, Natural Killer
- T-Cells, Natural Killer
- NKT Cells
- Natural Killer T-Cell
- Natural Killer T Cell
- NKT Cell
|
Below are MeSH descriptors whose meaning is more general than "Natural Killer T-Cells".
Below are MeSH descriptors whose meaning is more specific than "Natural Killer T-Cells".
This graph shows the total number of publications written about "Natural Killer T-Cells" by people in this website by year, and whether "Natural Killer T-Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 4 | 0 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 4 | 1 | 5 |
| 2013 | 1 | 1 | 2 |
| 2014 | 3 | 2 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 5 | 0 | 5 |
| 2018 | 5 | 2 | 7 |
| 2019 | 7 | 1 | 8 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 5 | 0 | 5 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Natural Killer T-Cells" by people in Profiles.
-
Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells. Proc Natl Acad Sci U S A. 2024 Aug 20; 121(34):e2321686121.
-
IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity. Nat Commun. 2024 01 02; 15(1):89.
-
Tregs protect against invariant NKT cell-mediated autoimmune colitis and hepatitis. Immunology. 2024 Feb; 171(2):277-285.
-
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2023 Jun; 29(6):1379-1388.
-
Profiling of innate and adaptive immune cells during influenza virus infection reveals sex bias in invariant natural killer T (iNKT) cells. Immun Inflamm Dis. 2023 04; 11(4):e837.
-
Natural killer T cells and other innate-like T?lymphocytes as emerging platforms for allogeneic cancer cell therapy. Blood. 2023 02 23; 141(8):869-876.
-
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells. Cancer Immunol Res. 2023 02 03; 11(2):171-183.
-
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Adv. 2022 01 25; 6(2):452-459.
-
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021 09 09; 138(10):858-870.
-
Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor a Chain Foster Local Environment for Type 1 Innate Like T Cell Development. Front Immunol. 2021; 12:623280.